| Name | butein |
|---|---|
| Synonyms |
Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI)
Einecs -5 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propene-1-one 2-[2-(2-aminophenyl)ethenyl]-5-methyl-quinolin-8-ol Butein (NSC-652892 2-[2-(2-aminophenyl)ethenyl]-5-methylquinolin-8-ol (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one Butein,2',3,4,4'-Tetrahydroxychalcone 2-[(E)-2-(2-aminophenyl)vinyl]-5-methyl-quinolin-8-ol BUTANOL Butein, 10 mM in DMSO 3,4,2',4'-TETRAHYDROXYCHALCONE 2-[2-(2-aminophenyl)vinyl]-5-methylquinolin-8-ol Butein - - Calbiochem Butein 2',3,4,4'-Tetrahydroxychalcone 2',3,4,4'-TETRAHYDROXYCHALCONE (2E) BUTEIN Butein > 2′,3,4,4′-Tetrahydroxychalcone MFCD00017300 BUTEIN(P) (E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one 2-[2-(2-aminophenyl)vinyl]-5-methyl-quinolin-8-ol Butein, c-Met and EGFR tyrosine kinase inhibitor (2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one (2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one PDE4,idermal owth factor rector,Inhibitor,EGFR,MAPK,ErbB-1,Apoptosis,Autophagy,FoxO3a,inhibit,cell,SIRT1,Phosphodiesterase (PDE),ERK,PKB,Butein,AKT,HeLa,HER1,p38,HG2 2-[(E)-2-(2-aminophenyl)vinyl]-5-methyl-8-quinolinol Einecs 207-659-5 1-(2,4-DIHYDROXYPHENYL)-3-(3,4-DIHYDROXYPHENYL)-2-PROPEN-1-ONE AC 1NQY7L) 2',3,4,4'-TETRAHYDROCHALCONE (E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one 2',3,4,4'-Tetrahydroxychalcone 2-[2-(2-aminophenyl)vinyl]-5-methyl-8-quinolinol 2',3,4,4'-Tetrahydroxy-trans-chalcone Butein Butein 2-[(E)-2-(2-aminophenyl)ethenyl]-5-methylquinolin-8-ol 2-[(E)-2-(2-aminophenyl)ethenyl]-5-methyl-quinolin-8-ol QR CQ DV1U1R CQ DQ &&E Form 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E) BUTEIN(SH) CCG208298 (E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one 2',4',3,4-TETRAHYDROXYCHALCONE |
| Description | Butein, a plant polyphenol isolated from Rhus verniciflua, inhibit the activation of protein tyrosine kinase and EGFR. target: EGFR [1]In vitro: 1) Butein inhibited the activation of AKT, extracellular signal-regulated kinase (ERKs) and p38 kinases in the presence of cisplatin.[2] 2) FoxO3a and its downstream molecules play a role in the synergistic effects of butein and cisplatin.[2]3) Butein suppresses cell proliferation and enhances apoptosis in paclitaxel-resistant ovarian cancer cells.[3]4) Butein activates FOXO3a/p27kip1 pathway in ALL cell lines.[4]5) Butein inhibited not only the epidermal growth factor (EGF)-stimulated auto-phosphotyrosine level of EGF receptor in HepG2 cells but also tyrosine-specific protein kinase activities of EGF receptor (IC50= 65 μM) and p60c-src(IC50= 65 μM)In vivo: 1) Butein in combination with cisplatin suppresses tumor growth and increases FoxO3a expression.[1] |
|---|---|
| Related Catalog | |
| Target |
EGFR |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 560.9±50.0 °C at 760 mmHg |
| Melting Point | 216°C |
| Molecular Formula | C15H12O5 |
| Molecular Weight | 272.25 |
| Flash Point | 307.1±26.6 °C |
| PSA | 17.07000 |
| LogP | 2.66 |
| Appearance | solid | yellow |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.748 |
| Storage condition | -20°C |
| Water Solubility | DMSO: >50 mg/mL |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| Precursor 9 | |
|---|---|
| DownStream 6 | |